Obinutuzumab vs. Ibrutinib in the Treatment of Treatment-Naïve Patients with Chronic Lymphocytic Leukemia —A Cost-Comparison Study in Colombia

Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2577
https://www.valueinhealthjournal.com/article/S1098-3015(17)32911-X/fulltext
Section Title : SELECTED HEALTH CARE TREATMENT STUDIES -MEDICAL DEVICE/DIAGNOSTICS
Section Order : 2374
First Page : A875
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32911-X&doi=10.1016/j.jval.2017.08.2577
HEOR Topics :
Tags :
Regions :